Lucheng Zhu Shenglin Ma Bing Xia
10.3389/fonc.2022.1009076
Front Oncol
2022 Nov 9;12:1009076.
alk inhibitor strn-alk fusion alectinib case report thyroid cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/36439495/
Case Reports
PMC9682147
36439495
Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report
2022